Source: Health Products Regulatory Authority (ZA) Publisher: CIPLA MEDPRO (PTY) LTD., Building 9, Parc du Cap, Mispel Street, Bellville, 7530
ZOPIVANE (7,5 mg film-coated tablets).
| Pharmaceutical Form |
|---|
|
Film-coated tablets. White, film coated, oblong-shaped, shallow convex tablets with central breakline on one side and plain on the other side. |
Each tablet contains zopiclone 7,5 mg.
Contains sugar: lactose monohydrate 40,000 mg per tablet.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Zopiclone is a hypnotic agent belonging to the cyclopyrrolone class of psychotherapeutic agents. It rapidly initiates and sustains sleep without reduction of total REM sleep and with preservation of slow wave sleep. Negligible residual effects are seen the following morning. Its pharmacological properties include hypnotic, sedative, anxiolytic, anticonvulsant and muscle-relaxant actions. |
| List of Excipients |
|---|
|
Tablet core: Colloidal silicon dioxide (Aerosil 200) Tablet coating: Opadry QX321A180025 Opadry QX321A180025: Glycerol monocaprylocaprate |
ZOPIVANE tablets are supplied in blister strips of 10 tablets, packed in 30’s in a carton.
CIPLA MEDPRO (PTY) LTD., Building 9, Parc du Cap, Mispel Street, Bellville, 7530
35/2.2/0021
10 January 2023
| Drug | Countries | |
|---|---|---|
| ZOPIVANE | Hong Kong, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.